| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | -44.3% | +34.7% |
| Cost of Revenue | $1.3M | -41.7% | -15.3% |
| Gross Profit | -$130K | -2.4% | +80.7% |
| R&D Expense | $951K | +28.0% | -1.0% |
| SG&A Expense | $2.4M | -9.2% | -14.4% |
| Operating Income | -$3.5M | +1.0% | +21.5% |
| Pre-tax Income | -$10.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.8M | +586.1% | — |
| Inventory | $6.6M | -6.3% | — |
| Current Assets | $11.6M | +20.2% | — |
| Total Assets | $13.5M | +15.5% | — |
| Current Liabilities | $5.4M | -88.2% | — |
| Total Liabilities | $5.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.3M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $14.1M | — | — |
| -55.1% |
| -68.0% |
| Income Tax | $0 | — | — |
| Net Income | -$10.4M | -55.1% | -68.0% |
| EPS (Basic) | -$0.19 | — | +78.2% |
| -87.9% |
| — |
| Stockholders' Equity | $8.0M | +114.6% | +122.5% |